F
Fabrizio Salvi
Researcher at University of Bologna
Publications - 221
Citations - 14278
Fabrizio Salvi is an academic researcher from University of Bologna. The author has contributed to research in topics: Transthyretin & Chronic cerebrospinal venous insufficiency. The author has an hindex of 56, co-authored 213 publications receiving 12721 citations. Previous affiliations of Fabrizio Salvi include Academy for Urban School Leadership & University of Ferrara.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial.
Paolo Zamboni,Antonio Bertolotto,Paolo Boldrini,Patrizia Cenni,Roberto D'Alessandro,Roberto D'Amico,Massimo Del Sette,Roberto Galeotti,Stefania Galimberti,Alessandro Liberati,Luca Massacesi,Donato Papini,Fabrizio Salvi,Silvana Simi,Andrea Stella,Luigi Tesio,Maria Grazia Valsecchi,Graziella Filippini +17 more
TL;DR: This study will provide an answer regarding the efficacy of PTA on patients’ functional disability in balance, motor, sensory, visual and bladder function, cognitive status, and emotional status, which are meaningful clinical outcomes, beyond investigating the effects on inflammation.
Journal ArticleDOI
Transient regression of an intracranial germ cell tumour after intravenous steroid administration: a case report
TL;DR: Magnetic resonance imaging showed transient regression of the lesion after intravenous steroid administration in a patient with intracranial multifocal germ cell tumour, and Germ cell tumours must be included in the differential diagnosis of intrac Cranial mass lesions sensitive to steroids.
Journal ArticleDOI
Amyotrophic lateral sclerosis with mutation of the Cu/Zn superoxide dismutase gene (SOD1) in a patient with Down syndrome.
Gianluca Marucci,Luca Morandi,Ilaria Bartolomei,Fabrizio Salvi,Annalisa Pession,Alberto Righi,Giuseppe Lauria,Maria Pia Foschini +7 more
TL;DR: The missense mutation of SOD1 gene in two of the three alleles could have increased its toxic effects in the Down syndrome patient leading to an earlier onset and rapid progression of the disease.
Journal ArticleDOI
Homozygosity and heterozygosity for the transthyretin Leu64 mutation: clinical, biochemical and molecular findings.
Alessandra Ferlini,Fabrizio Salvi,Antonino Uncini,Jasmin El-Chami,Pia Winter,Klaus Altland,Monica Repetto,Massimo Littardi,Andrea Campoleoni,Paolo Vezzoni,Maria Cristina Patrosso +10 more
TL;DR: The clinical picture of the homozygous patient of Family B was more severe than that shown by the heterozygous members of Family A, but the variability often displayed by FAP patients does not allow any firm conclusion about the role of homozygosity in the seriousness of the disease.
Journal ArticleDOI
Regional Cerebral Disease Progression in Friedreich's Ataxia: A Longitudinal Diffusion Tensor Imaging Study.
Mario Mascalchi,Nicola Toschi,Nicola Toschi,Marco Giannelli,Andrea Ginestroni,Riccardo Della Nave,Carlo Tessa,Silvia Piacentini,Maria Teresa Dotti,Marco Aiello,Emanuele Nicolai,Andrea Soricelli,Fabrizio Salvi,Stefano Diciotti +13 more
TL;DR: The potential of brain MR morphometry and diffusion tensor imaging (DTI) to track the progression of neurodegeneration in FRDA is explored.